Erratum: Semaphorins and tumor angiogenesis (Angiogenesis DOI 10.1007/s10456-009-9138-4);Semaphorins and tumor angiogenesis

Angiogenesis

Volumn 12, Issue 2, 2009, Pages 187-193

  Serini, Guido ^a,b   Maione, Federica ^a,b   Giraudo, Enrico ^a,b   Bussolino, Federico ^a,b  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Autocrine loop; Integrin; Tumor growth

Indexed keywords

ANGIOGENESIS INHIBITOR; NEUROPILIN; PLEXIN; SEMAPHORIN; TYROSINE KINASE RECEPTOR; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; CANCER INHIBITION; CANCER RESISTANCE; CARDIOVASCULAR SYSTEM; DRUG POTENTIATION; GENE FUNCTION; GROWTH REGULATION; HUMAN; IMMUNE SYSTEM; MEMBRANE BINDING; NEOPLASM; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE STRUCTURE; TUMOR PROMOTION; TUMOR VASCULARIZATION; VASCULAR TISSUE;

MAMMALIA;

EID: 67650735731     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-009-9149-1     Document Type: Erratum

References (71)

1. TS Tran 2007 Semaphorin regulation of cellular morphology Annu Rev Cell Dev Biol 23 263 292 10.1146/annurev.cellbio.22.010605.093554
2. F Bussolino 2006 Semaphoring vascular morphogenesis Endothelium 13 81 91 10.1080/10623320600698003
3. AD Gitler 2004 PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development Dev Cell 7 107 116 10.1016/j.devcel.2004.06.002
4. Y Zhang 2009 Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defects Dev Biol 325 82 93 10.1016/j.ydbio.2008.09.031
5. G Neufeld O Kessler 2008 The semaphorins: versatile regulators of tumour progression and tumour angiogenesis Nat Rev Cancer 8 632 645 10.1038/nrc2404
6. Y Zhou 2008 Semaphorin signaling: progress made and promises ahead Trends Biochem Sci 33 161 170 10.1016/j.tibs.2008.01.006
7. BH Luo TA Springer 2006 Integrin structures and conformational signaling Curr Opin Cell Biol 18 579 586 10.1016/j.ceb.2006.08.005
8. D Valdembri 2009 Neuropilin-1/GIPC1 signaling regulates α5β1 integrin traffic and function in endothelial cells PLoS Biol 7 1 e1000025 10.1371/journal.pbio.1000025
9. D Barberis 2004 Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility FASEB J 18 592 594
10. B Butler 2006 Purified integrin adhesion complexes exhibit actin-polymerization activity Curr Biol 16 242 251 10.1016/j.cub.2005.12.033
11. T Takahashi SM Strittmatter 2001 Plexina1 autoinhibition by the plexin sema domain Neuron 29 429 439 10.1016/S0896-6273(01)00216-1
12. I Oinuma 2004 The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras Science 305 862 865 10.1126/science.1097545
13. M Negishi 2005 R-ras as a key player for signaling pathway of plexins Mol Neurobiol 32 217 222 10.1385/MN:32:3:217
14. I Oinuma 2004 Molecular dissection of the semaphorin 4D receptor plexin-B1-stimulated R-Ras GTPase-activating protein activity and neurite remodeling in hippocampal neurons J Neurosci 24 11473 11480 10.1523/JNEUROSCI. 3257-04.2004
15. K Kinbara 2003 Ras GTPases: integrins' friends or foes? Nat Rev Mol Cell Biol 4 767 776 (Pubitemid 37229373)
16. T Toyofuku 2005 FARP2 triggers signals for Sema3A-mediated axonal repulsion Nat Neurosci 8 1712 1719 10.1038/nn1596
17. DR Critchley AR Gingras 2008 Talin at a glance J Cell Sci 121 1345 1347 10.1242/jcs.018085
18. P Conrotto 2005 Sema4D induces angiogenesis through Met recruitment by Plexin B1 Blood 105 4321 4329 10.1182/blood-2004-07-2885
19. JR Basile 2004 Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B Cancer Res 64 5212 5224 10.1158/0008-5472.CAN-04-0126
20. JR Basile 2005 Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway Mol Cell Biol 25 6889 6898 10.1128/MCB.25.16.6889-6898.2005
21. JM Swiercz 2004 Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2 J Cell Biol 165 869 880 10.1083/jcb.200312094
22. JM Swiercz 2008 ERBB-2 and met reciprocally regulate cellular signaling via plexin-B1 J Biol Chem 283 1893 1901 10.1074/jbc.M706822200
23. T Toyofuku 2007 Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1 EMBO J 26 1373 1384 10.1038/sj.emboj. 7601589
24. S Soker 1998 Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor Cell 92 735 745 10.1016/S0092-8674(00)81402-6
25. T Kawasaki 1999 A requirement for neuropilin-1 in embryonic vessel formation Development 126 4895 4902
26. B Favier 2006 Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration Blood 108 1243 1250 10.1182/blood-2005-11-4447
27. T Karpanen 2006 Functional interaction of VEGF-C and VEGF-D with neuropilin receptors FASEB J 20 1462 1472 10.1096/fj.05-5646com
28. A Matsushita 2007 Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1 Cancer Res 67 10309 10316 10.1158/0008-5472.CAN-07-3256
29. BA Appleton 2007 Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding EMBO J 26 4902 4912 10.1038/sj.emboj.7601906
30. HQ Miao 1999 Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165 J Cell Biol 146 233 242
31. DC West 2005 Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2 J Biol Chem 280 13457 13464 10.1074/jbc.M410924200
32. M Migdal 1998 Neuropilin-1 is a placenta growth factor-2 receptor J Biol Chem 273 22272 22278 10.1074/jbc.273.35.22272
33. Y Glinka GJ Prud'homme 2008 Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity J Leukoc Biol 84 302 310 10.1189/jlb.0208090
34. B Hu 2007 Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway Oncogene 26 5577 5586 10.1038/sj.onc.1210348
35. S Banerjee 2006 Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1 Mol Carcinog 45 871 880 10.1002/mc.20248
36. SH Hsieh 2008 Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells Oncogene 27 3746 3753 10.1038/sj.onc.1211029
37. Y Herzog 2005 Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation Dev Dyn 232 1047 1055 10.1002/dvdy.20257
38. Y Herzog 2001 Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins Mech Dev 109 115 119 10.1016/S0925-4773(01)00518-4
39. T Toyofuku 2004 Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2 Genes Dev 18 435 447 10.1101/gad.1167304
40. F Bussolino 1992 Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth J Cell Biol 119 629 641 10.1083/jcb.119.3.629
41. C Gu 2005 Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins Science 307 265 268 10.1126/science.1105416
42. O Behar 1996 Semaphorin III is needed for normal patterning and growth of nerves, bones and heart Nature 383 525 528 10.1038/383525a0
43. T Kanda 2007 PlexinD1 deficiency induces defects in axial skeletal morphogenesis J Cell Biochem 101 1329 1337 10.1002/jcb.21306
44. DA Towler 2007 Vascular biology and bone formation: hints from HIF J Clin Invest 117 1477 1480 10.1172/JCI32518
45. Y Wang 2007 The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development J Clin Invest 117 1616 1626 10.1172/JCI31581
46. C Gomez 2005 Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation Dev Dyn 234 393 403 10.1002/dvdy.20512
47. M Futamura 2007 Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression Cancer Res 67 1451 1460 10.1158/0008-5472.CAN-06-2485
48. Y Sekido 1996 Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns Proc Natl Acad Sci USA 93 4120 4125 10.1073/pnas.93.9.4120
49. VA Potiron 2009 Semaphorins and their receptors in lung cancer Cancer Lett 273 1 14 10.1016/j.canlet.2008.05.032
50. DR Bielenberg 2004 Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype J Clin Invest 114 1260 1271 (Pubitemid 40385297)
51. O Kessler 2004 Semaphorin-3F is an inhibitor of tumor angiogenesis Cancer Res 64 1008 1015 10.1158/0008-5472.CAN-03-3090
52. G Serini 2003 Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function Nature 424 391 397 10.1038/nature01784
53. LM Acevedo 2008 Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor Blood 111 2674 2680 10.1182/blood-2007- 08-110205
54. G Serini 2008 Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis Curr Opin Hematol 15 235 242 10.1097/MOH.0b013e3282fa745b
55. Maione F et al. (2009) Semaphorin 3A is an endogenous angiogenic inhibitor that blocks tumor growth and normalizes the vasculature in a mouse model of multistage tumorigenesis. J Clin Invest (submitted)
56. G Serini 2006 Integrins and angiogenesis: a sticky business Exp Cell Res 312 651 658 10.1016/j.yexcr.2005.10.020
57. O Casanovas 2005 Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors Cancer Cell 8 299 309 10.1016/j.ccr.2005.09.005
58. RK Jain 2008 Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer Nat Rev Cancer 8 309 316 10.1038/nrc2346
59. RK Jain 2005 Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 58 62 10.1126/science.1104819
60. RK Jain 2007 Angiogenesis in brain tumours Nat Rev Neurosci 8 610 622 10.1038/nrn2175
61. S Lee 2007 Autocrine VEGF signaling is required for vascular homeostasis Cell 130 691 703 10.1016/j.cell.2007.06.054
62. G Serini 2003 Modeling the early stages of vascular network assembly EMBO J 22 1771 1779 10.1093/emboj/cdg176
63. N Tang 2004 Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis Cancer Cell 6 485 495 10.1016/j.ccr.2004.09.026
64. DH Damon 2006 Vascular endothelial-derived semaphorin 3 inhibits sympathetic axon growth Am J Physiol Heart Circ Physiol 290 H1220 H1225 10.1152/ajpheart.01232.2004
65. T Ito 2000 Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung Mech Dev 97 35 45 10.1016/S0925-4773(00)00401- 9
66. A Vacca 2006 Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma Blood 108 1661 1667 10.1182/blood-2006-04-014563
67. JR Basile 2007 Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility J Biol Chem 282 34888 34895 10.1074/jbc.M705467200
68. JR Basile 2006 Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis Proc Natl Acad Sci USA 103 9017 9022 10.1073/pnas.0508825103
69. JR Sierra 2008 Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages J Exp Med 205 1673 1685 10.1084/jem.20072602
70. S Giordano 2002 The semaphorin 4D receptor controls invasive growth by coupling with Met Nat Cell Biol 4 720 724 10.1038/ncb843
71. J Folkman 2006 Angiogenesis Annu Rev Med 57 1 8 10.1146/annurev.med.57. 121304.131306